Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung ...
This interactive map explains where COPD rates, hospitalizations, and deaths are highest across the United States.
St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive disease (COPD)/emphysema. COPD affects the lungs and their ability to ...
In acute infective exacerbation of chronic bronchitis or chronic obstructive pulmonary disease (COPD), adding erdosteine to standard treatment significantly modified the outcome by improving the ...
People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis who do not have COPD, according to a new study.
FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies.
The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...
It includes two primary conditions: chronic bronchitis, inflammation of your bronchial tubes emphysema, damage to the air sacs in your lungs The inflammation and damage in COPD make breathing ...
COPD affects the lungs and their ability to ... with 3.5 million also diagnosed with emphysema, which is life-threatening with no cure. The new treatment, the Zephyr Valve, aims to help ease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results